
Pratibha Binder, MD, discusses how the introduction of novel immune checkpoint inhibitors into frontline treatment strategies could ameliorate unmet needs in endometrial cancer.

Your AI-Trained Oncology Knowledge Connection!


Pratibha Binder, MD, discusses how the introduction of novel immune checkpoint inhibitors into frontline treatment strategies could ameliorate unmet needs in endometrial cancer.

Pratibha Binder, MD, discusses key trials improving the array of treatment options for patients with endometrial cancer.